<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04772261</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-CD-050</org_study_id>
    <nct_id>NCT04772261</nct_id>
  </id_info>
  <brief_title>GEBT Lot-to-Lot and Biological Variability</brief_title>
  <official_title>13C-Spirulina Breath Test (13C-GEBT) Lot-to-Lot and Biological Variability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairn Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairn Diagnostics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect information regarding lot-to-lot variability in&#xD;
      13C-Spirulina test meal lets and within-subject biological variability.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study participants will participate in one or two arms of the study. In one arm the&#xD;
      participants will be administered GEBT tests that contain different 13C-Spirulina/Egg mix&#xD;
      drug lots. In the second arm, the participants will be administered GEBT tests from the same&#xD;
      13C-Spirulina/Egg mix drug lot. All GEBT kit lots will be administered according to the&#xD;
      FDA-approved labeling.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 5, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lot to Lot Variability</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Participant kPCD values at each measured timepoint from each lot of 13C-Spirulina GEBT test meal will be plotted to compare in vivo results across each lot of material</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lot to Lot Variability</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Pooled kPCD and standard deviations for each measured timepoint from each lot of 13C-Spirulina GEBT test meal will be calculated and compared for the lot-to-lot comparisons</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lot to Lot Variability</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Each set of pooled 13C-Spirulina test meal lot kPCD values will be calculated using a t-test or ANOVA to determine statistical equivalence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biological Variability</measure>
    <time_frame>Up to 3 months</time_frame>
    <description>Participant kPCD values at each measured timepoint from the same 13C-Spirulina GEBT test meal will be plotted to compare against each other</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biological Variability</measure>
    <time_frame>Up to 3 months</time_frame>
    <description>Pooled, within subject standard deviations of duplicate measurements of kPCD values at each measured timepoint from the same lot of 13C-Spirulina GEBT test meal will be calculated for biological variation using Bartlett's test for homogeneity of variances</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Gastroparesis</condition>
  <arm_group>
    <arm_group_label>Lot-to-Lot Variability</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be administered up to six different 13C-Spirulina test meal lots</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biological Variability</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be administered the same 13C-Spirulina test meal lot on two different occasions</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>13C-Spirulina GEBT</intervention_name>
    <description>Various lots of 13C-Spirulina GEBT test meals</description>
    <arm_group_label>Biological Variability</arm_group_label>
    <arm_group_label>Lot-to-Lot Variability</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females, 18-85 years old at time of signing the informed consent form&#xD;
&#xD;
          -  Ability to eat test meal and provide breath samples&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History or physical exam suggestive of systemic disease such as diabetes mellitus or&#xD;
             pathophysiologic disorders such as renal failure, chronic heart disease, chronic&#xD;
             respiratory disease, liver disease, or malabsorption.&#xD;
&#xD;
          -  History of abdominal surgery except appendectomy&#xD;
&#xD;
          -  Use of any medications that may alter gastric motility within two days of the study&#xD;
&#xD;
          -  Use of narcotics or anticholinergics within two days of the study&#xD;
&#xD;
          -  Females on hormone replacement therapy other than birth control medications&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Intolerance or allergy to any component of GEBT test meal&#xD;
&#xD;
          -  History of neurologic or psychiatric disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alex Ryder, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairn Diagnostics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairn Diagnostics</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <zip>37027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastroenterology</keyword>
  <keyword>Gastric emptying breath test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/61/NCT04772261/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

